226 related articles for article (PubMed ID: 25225661)
1. MCPIP1 suppresses hepatitis C virus replication and negatively regulates virus-induced proinflammatory cytokine responses.
Lin RJ; Chu JS; Chien HL; Tseng CH; Ko PC; Mei YY; Tang WC; Kao YT; Cheng HY; Liang YC; Lin SY
J Immunol; 2014 Oct; 193(8):4159-68. PubMed ID: 25225661
[TBL] [Abstract][Full Text] [Related]
2. MCPIP1 inhibits Hepatitis B virus replication by destabilizing viral RNA and negatively regulates the virus-induced innate inflammatory responses.
Li M; Yang J; Zhao Y; Song Y; Yin S; Guo J; Zhang H; Wang K; Wei L; Li S; Xu W
Antiviral Res; 2020 Feb; 174():104705. PubMed ID: 31926181
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
[TBL] [Abstract][Full Text] [Related]
4. MCPIP1 inhibits coxsackievirus B3 replication by targeting viral RNA and negatively regulates virus-induced inflammation.
Li M; Yan K; Wei L; Yang Y; Qian Q; Xu W
Med Microbiol Immunol; 2018 Feb; 207(1):27-38. PubMed ID: 29043433
[TBL] [Abstract][Full Text] [Related]
5. Relationships between hepatitis C virus replication and CXCL-8 production in vitro.
Koo BC; McPoland P; Wagoner JP; Kane OJ; Lohmann V; Polyak SJ
J Virol; 2006 Aug; 80(16):7885-93. PubMed ID: 16873245
[TBL] [Abstract][Full Text] [Related]
6. MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation.
Lin RJ; Chien HL; Lin SY; Chang BL; Yu HP; Tang WC; Lin YL
Nucleic Acids Res; 2013 Mar; 41(5):3314-26. PubMed ID: 23355615
[TBL] [Abstract][Full Text] [Related]
7. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
8. An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection.
Liu S; Zhang Q; Shao X; Wang W; Zhang C; Jin Z
Int Immunopharmacol; 2017 Sep; 50():87-94. PubMed ID: 28644966
[TBL] [Abstract][Full Text] [Related]
9. MCPIP1 reduces HBV-RNA by targeting its epsilon structure.
Li Y; Que L; Fukano K; Koura M; Kitamura K; Zheng X; Kato T; Aly HH; Watashi K; Tsukuda S; Aizaki H; Watanabe N; Sato Y; Suzuki T; Suzuki HI; Hosomichi K; Kurachi M; Wakae K; Muramatsu M
Sci Rep; 2020 Nov; 10(1):20763. PubMed ID: 33247161
[TBL] [Abstract][Full Text] [Related]
10. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.
Larrea E; Aldabe R; Molano E; Fernandez-Rodriguez CM; Ametzazurra A; Civeira MP; Prieto J
Gut; 2006 Aug; 55(8):1188-96. PubMed ID: 16120756
[TBL] [Abstract][Full Text] [Related]
11. USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation.
Kusakabe S; Suzuki T; Sugiyama Y; Haga S; Horike K; Tokunaga M; Hirano J; Zhang H; Chen DV; Ishiga H; Komoda Y; Ono C; Fukuhara T; Yamamoto M; Ikawa M; Satoh T; Akira S; Tanaka T; Moriishi K; Fukai M; Taketomi A; Yoshio S; Kanto T; Suzuki T; Okamoto T; Matsuura Y
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626683
[TBL] [Abstract][Full Text] [Related]
12. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology.
Ng TI; Mo H; Pilot-Matias T; He Y; Koev G; Krishnan P; Mondal R; Pithawalla R; He W; Dekhtyar T; Packer J; Schurdak M; Molla A
Hepatology; 2007 Jun; 45(6):1413-21. PubMed ID: 17518369
[TBL] [Abstract][Full Text] [Related]
13. Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells.
Frentzen A; Anggakusuma ; Gürlevik E; Hueging K; Knocke S; Ginkel C; Brown RJ; Heim M; Dill MT; Kröger A; Kalinke U; Kaderali L; Kuehnel F; Pietschmann T
Hepatology; 2014 Jan; 59(1):78-88. PubMed ID: 23873628
[TBL] [Abstract][Full Text] [Related]
14. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
[TBL] [Abstract][Full Text] [Related]
16. Selective degradation of plasmid-derived mRNAs by MCPIP1 RNase.
Qian Y; Li X; Miao R; Liu S; Xin HB; Huang X; Wang TT; Fu M
Biochem J; 2019 Oct; 476(19):2927-2938. PubMed ID: 31530713
[TBL] [Abstract][Full Text] [Related]
17. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
Kasai D; Adachi T; Deng L; Nagano-Fujii M; Sada K; Ikeda M; Kato N; Ide YH; Shoji I; Hotta H
J Hepatol; 2009 May; 50(5):883-94. PubMed ID: 19303158
[TBL] [Abstract][Full Text] [Related]
18. The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.
Shlomai A; Rechtman MM; Burdelova EO; Zilberberg A; Hoffman S; Solar I; Fishman S; Halpern Z; Sklan EH
J Hepatol; 2012 Oct; 57(4):867-73. PubMed ID: 22732512
[TBL] [Abstract][Full Text] [Related]
19. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
Itsui Y; Sakamoto N; Kurosaki M; Kanazawa N; Tanabe Y; Koyama T; Takeda Y; Nakagawa M; Kakinuma S; Sekine Y; Maekawa S; Enomoto N; Watanabe M
J Viral Hepat; 2006 Oct; 13(10):690-700. PubMed ID: 16970601
[TBL] [Abstract][Full Text] [Related]
20. MCPIP1/regnase-I inhibits simian immunodeficiency virus and is not counteracted by Vpx.
Li H; Wang TT
J Gen Virol; 2016 Jul; 97(7):1693-1698. PubMed ID: 27075251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
